The COVAIL trial reveals that neutralizing antibody titers correlate with COVID-19 risk reduction after mRNA boosters. Learn how this impacts vaccine strategies against emerging variants.

A comprehensive study of U.S. veterans reveals that COVID-19 leads to higher long-term mortality compared to influenza and RSV, emphasizing the critical role of vaccination in reducing severe outcomes ...

Increased use of ventilation and air cleaners, designed to mitigate the spread of viral infections in hospitals, is likely to have unpredictable effects and may cause viral particles to move around ...

A newly declassified report, released by the CIA on Saturday, is once again stoking the debate around the origins of SARS-CoV ...

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

The following is a summary of “Identification of patient demographic, clinical, and SARS-CoV-2 genomic factors associated with severe COVID-19 using supervised machine learning: a retrospective ...

On his first day in office, President Donald Trump signed an executive order withdrawing the U.S. from the World Health ...

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

Get up-to-date information on the dynamics of COVID-19 variants in Toronto. Discover how this research can aid in fighting ...

Bats harbor many viruses that can spill over into humans, including Marburg, Ebola, and famously SARS-CoV-2. But while these ...